Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Interleukin-4

Das IL4-Gen kodiert Interleukin-4 ein wichtiges Zytokin, welches von aktivierten T-Lymphozyten produziert wird. Damit besitzt es eine wichtige Regulatorfunktion bei Immunprozessen.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Referenzen:

1.

Horsley V et al. (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth.

external link
2.

Saltman DL et al. (1993) A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization.

external link
3.

Kotanides H et al. (1996) Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene.

external link
4.

Kawashima T et al. (1998) Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families.

external link
5.

Dickensheets HL et al. (1999) Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.

external link
6.

Hunt PJ et al. (2000) Cytokine gene polymorphisms in autoimmune thyroid disease.

external link
7.

Carvalho LH et al. (2002) IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages.

external link
8.

Inoue T et al. (2002) Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis.

external link
9.

Ozaki K et al. (2002) A critical role for IL-21 in regulating immunoglobulin production.

external link
10.

Ghoreschi K et al. (2003) Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.

external link
11.

Messi M et al. (2003) Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes.

external link
12.

Zavros Y et al. (2003) Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

external link
13.

Zee RY et al. (2004) Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.

external link
14.

Nguyen KD et al. (2011) Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis.

external link
15.

Vijayanand P et al. (2012) Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V.

external link
16.

Harada Y et al. (2012) The 3' enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells.

external link
17.

Reese TA et al. (2014) Helminth infection reactivates latent γ-herpesvirus via cytokine competition at a viral promoter.

external link
18.

Osborne LC et al. (2014) Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation.

external link
19.

Minutti CM et al. (2017) Local amplifiers of IL-4Rα-mediated macrophage activation promote repair in lung and liver.

external link
20.

Leung DY et al. (1988) Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome.

external link
21.

Fields PE et al. (2002) Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation.

external link
22.

Spilianakis CG et al. (2005) Interchromosomal associations between alternatively expressed loci.

external link
23.

Sutherland GR et al. (1988) Interleukin 4 is at 5q31 and interleukin 6 is at 7p15.

external link
24.

Smirnov DV et al. (1995) Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization.

external link
25.

Loots GG et al. (2000) Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons.

external link
26.

Lacy DA et al. (2000) Faithful expression of the human 5q31 cytokine cluster in transgenic mice.

external link
27.

Kelly-Welch AE et al. (2003) Interleukin-4 and interleukin-13 signaling connections maps.

external link
28.

LaPorte SL et al. (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.

external link
29.

Wu D et al. (2011) Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis.

external link
30.

Bosurgi L et al. (2017) Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells.

external link
31.

Le Beau MM et al. (1993) Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.

external link
32.

Arai N et al. (1989) Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression.

external link
33.

Takahashi M et al. (1989) Chromosomal mapping of the mouse IL-4 and human IL-5 genes.

external link
34.

Le Beau MM et al. (1989) Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).

external link
35.

Yokota T et al. (1986) Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities.

external link
36.

Eder A et al. (1988) The 5' region of the human interleukin 4 gene: structure and potential regulatory elements.

external link
37.

Lewis DB et al. (1993) Osteoporosis induced in mice by overproduction of interleukin 4.

external link
38.

NCBI article

NCBI 3565 external link
39.

OMIM.ORG article

Omim 147780 external link
40.

Wikipedia Artikel

Wikipedia DE (Interleukine) external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz